# The Role of Hyaluronic Acid in the Treatment of Gingivitis and Periodontitis at Different Stages: A Systematic Review and Meta-Analysis with Short-Term Follow-Up

**Authors:** Nansi López-Valverde, Norberto Quispe-López, Javier Flores Fraile, Antonio López-Valverde, Bruno Macedo de Sousa, José Antonio Blanco Rueda

PMC · DOI: 10.3390/bioengineering12111135 · 2025-10-22

## TL;DR

This study reviews how hyaluronic acid helps treat gum diseases like gingivitis and periodontitis by improving key clinical indicators compared to traditional treatments.

## Contribution

A systematic review and meta-analysis of HA's effectiveness in periodontal treatment with short-term follow-up.

## Key findings

- HA improves probing depth, bleeding on probing, clinical attachment level, and gingival index in periodontal treatment.
- Plaque index improvements with HA are close to statistically significant.
- Only two studies on severe periodontitis showed significant attachment gains over 1 mm after 12 months.

## Abstract

Periodontal diseases are inflammatory conditions that destroy the periodontal attachment apparatus. Hyaluronic acid (HA) has anti-inflammatory properties that make it a candidate for the adjuvant treatment of gingivitis and periodontitis. Our objective was to observe the role of HA in the variability of clinical parameters indicative of gingivitis/periodontitis by comparing it with conventional treatments or placebo. This systematic review and meta-analysis was conducted according to Cochrane guidelines, and searches were performed in PubMed, Embase, Cochrane Central, Scopus, and Web of Science (WOS) to identify eligible studies. Review Manager 5.4.1 and SPSS Statistics 30.0® were used to calculate standardized mean differences (SMDs) and 95% confidence intervals (CIs). The outcomes assessed were probing depth (PPD), bleeding on probing (BOP), clinical attachment level (CAL), plaque index (PI), and gingival index (GI). Sixteen randomized clinical trials (RCTs) with 947 subjects were included. HA as an adjunct to periodontal treatment improves the clinical parameters of PPD in the short and medium term (1–24 months, 12.5 average) (−0.51; 95% CI [−0.85 to −0.17]; p = 0.004), BOP, CAL and GI. Plaque indices (PI) approached statistical significance. Despite limitations and heterogeneity, the evidence reveals that only two of the included studies on severe periodontitis reported significant improvements in CAL gain and PPD reduction, with attachmet gains greater than 1 mm at 12 months of follow-up.

## Linked entities

- **Diseases:** gingivitis (MONDO:0002508), periodontitis (MONDO:0005076)

## Full-text entities

- **Diseases:** bleeding (MESH:D006470), Periodontal diseases (MESH:D010510), inflammatory (MESH:D007249), Gingivitis (MESH:D005891), PPD (MESH:C535387), Periodontitis (MESH:D010518)
- **Chemicals:** HA (MESH:D006820)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649663/full.md

---
Source: https://tomesphere.com/paper/PMC12649663